Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 BMS To Expand R&D in India | Contract Pharma

What are you searching for?

Sign in
Breaking News

BMS To Expand R&D in India

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bristol-Myers Squibb has plans to expand its R&D capabilities in India in collaboration with Biocon Ltd. and Accenture Ltd. According to a company statement, BMS will work with Biocon, India’s largest biotechnology firm, to set up a research facility in Bangalore to help its discovery and early drug development. The Bangalore facility will have the potential to accommodate more than 400 scientists.

BMS also entered a multi-year agreement with Accenture, a consulting firm, to include support for clinical data and document management, pharmacovigilance, and scientific writing functions in India. Accenture will also provide maintenance and support for R&D information systems, according to BMS.

“This broad expansion of R&D in India will allow us to grow competitively while maintaining our industry-leading position in productivity and innovation,” said Elliott Sigal, executive vice president of BMS.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics